-
公开(公告)号:DE59700356D1
公开(公告)日:1999-09-23
申请号:DE59700356
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:AT183393T
公开(公告)日:1999-09-15
申请号:AT97907081
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:AU705692B2
公开(公告)日:1999-05-27
申请号:AU1926197
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:NO905411A
公开(公告)日:1991-06-17
申请号:NO905411
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEUERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D277/22
CPC classification number: C07D417/06 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30
-
公开(公告)号:FI906141A
公开(公告)日:1991-06-16
申请号:FI906141
申请日:1990-12-13
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEYERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
16.
公开(公告)号:AU719576B2
公开(公告)日:2000-05-11
申请号:AU7407696
申请日:1996-12-02
Applicant: HOECHST AG
Inventor: KIRSCHBAUM BERND , MULLNER STEFAN , BARTLETT ROBERT
IPC: C12N15/09 , A61K38/00 , C07K14/00 , C07K14/47 , C12N5/10 , C12N9/90 , C12N15/55 , C12Q1/68 , C12Q1/6823 , C12Q1/6886 , C12N15/64 , C12N15/11 , C12P21/02
Abstract: Nucleic acid binding protein (I) with helicase activity, the mRNA of which (or its translation products) are strongly expressed in presence of leflunomide (II, i.e. 4-(N-(4-trifluoromethylphenyl)-5-methyl-isoxazole)) or compounds with similar activity is new. Also new are: (1) DNA (III) encoding (I), or parts of it, and sequences that hybridise under stringent conditions with (III); (2) vectors containing (III) or sequences antisense to (III) and (3) host cells containing (III) or the vectors.
-
公开(公告)号:TR9801862T2
公开(公告)日:1998-12-21
申请号:TR9801862
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
CPC classification number: C07D261/18 , A61K31/42 , A61K31/275 , A61K2300/00
-
公开(公告)号:TR199801862T2
公开(公告)日:1998-12-21
申请号:TR9801862
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:CZ9802985A3
公开(公告)日:1998-12-16
申请号:CZ298598
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
CPC classification number: C07D261/18 , A61K31/42 , A61K31/275 , A61K2300/00
-
公开(公告)号:NO984343D0
公开(公告)日:1998-09-18
申请号:NO984343
申请日:1998-09-18
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
-
-
-
-
-
-
-
-